Drug-drug interactions in patients with castration-resistant prostate cancer undergoing abiraterone therapy: Characterizing the scale of the problem. In vivo assessment of the therapeutic effects of ...
Combination casdatifan plus cabozantinib expansion cohort of phase 1 ARC-20 study in previously treated patients with clear cell renal cell carcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results